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Objective: We postulated that L-glutamate- and L-aspartate-enriched per- 
fusate would improve functional recovery of postischemic neonatal rabbit 
hearts. Methods: Isolated working neonatal rabbit hearts were perfused 
with Krebs-Henseleit buffer and then subjected to 1 hour of hypothermic 
cardioplegic arrest with St. Thomas' Hospital solution. Hearts were then 
reperfused with L-glutamate- and L-aspartate-enriched (20 mmol/L) 
Krebs-Henseleit buffer (AA-enriched Krebs-Henseleit buffer). Hearts 
reperfused with Krebs-Henseleit buffer alone acted as controls (experiment 
A). Another group of hearts underwent a similar protocol but were 
reperfused with the AA-enriched Krebs-Henseleit buffer with correction of 
the sodium content (experiment B). Results: Hearts reperfused with AA- 
enriched Krebs-Henseleit buffer showed a significant decrease in aortic flow 
at both 15 (p = 0.04) and 30 (p = 0.025) minutes compared with controls. 
Arrhythmias were frequent. Sodium content of the AA-enriched Krebs- 
Henseleit buffer was 174 -+ 0.5 mmol/L. In experiment B, hearts reperfused 
with the AA-enriched Krebs-Henseleit buffer with correction of the sodium 
content exhibited no difference in aortic flow and cardiac output at either 15 
or 30 minutes (p = 0.95 and 0.5 and 0.48 and 0.78, respectively) compared 
with controls. No arrhythmias were observed. The sodium content of the 
AA-enriched Krebs-Henseleit buffer was 146 +- 0.7 mmol/L. Conclusions: A 
beneficial effect on functional recovery of neonatal hearts reperfused with 
AA-enriched Krebs-Henseleit buffer was not demonstrated. (J Thorac 
Cardiovasc Surg 1997;113:462-6) 
O Ptimization of postischemic neonatal myocardial function remains an elusive goal. Amino acid 
supplementation of cardioplegic solutions has been 
advocated to improve protection of both adult 1-3 
and immature myocardium 4 after ischemia. How- 
ever, adult results are mixed 5 and experimental data 
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is lacking in neonatal hearts. Studies in the neonatal 
rabbit heart have been limited to models of hypoxia, 6 
which is a metabolically distinct condition from isch- 
emia. 7 No studies have examined the effects on func- 
tional recovery of postischemic neonatal working 
hearts reperfused with solutions enriched with amino 
acid substrates. Intuitively this should lead to sustained 
improvement in functional recovery on the basis of 
earlier studies. We investigated the effect of an amino 
acid-enriched reperfusate on functional recovery of 
postischemic neonatal hearts in a clinically relevant 
model of neonatal myocardial ischemia. 
Materials and methods 
Isolated working heart model. Neonatal 8- to 12-day- 
old rabbits were kept with their does until use. After 
premedication with intramuscular ketamine hydrochlo- 
ride (50 mg/kg) followed by intraperitoneal somnotol (40 
mg/kg) and heparin (50 units/kg), a tracheostomy was 
performed and the animal was connected to a Harvard 
rodent ventilator. Ventilation prevented hearts from be- 
coming ischemic before excision. After a median sternot- 
omy incision, the hearts were rapidly excised and mounted 
462  
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 113, Number 3 
Sett, Tearle, LeBlanc 4 6 3 
Table I. Prei~chernic control values in experiment A 
AoF CoF CO SP HR 
Group n (ml/min ) (ml/rnin ) (ml/min ) (ram Hg ) (beats/rnin ) 
G+A (20 mmol/L) 8 28.2 + 2.0 13.2 _+ 1.2 41.5 _+ 3.1 95.4 _+ 3.6 331 +_ 15 
K-H 8 24.1 _+ 1.7 12.3 -+ 1.2 36.3 _+ 2.8 87.3 _+ 4.2 319 _+ 16 
p Value 0.139 0.6 0.24 0.17 0.6 
Data are mean -+ standard error of the mean. 
AoF, Aortic flow; CoF, coronary flow; CO, cardiac output; SP, systolic pressure; FIR, heart rate; G+A, L -glutamate (20 mmol/L) + L-aspartate (20 mmol/L) 
and Krebs-Henseleit solution; K-H, Krebs Henseleit solution. 
Table II. Percent recovery of function at 15 minutes in working mode 
/loF CoF CO SP HR 
Group (ml/min) (ml/min) (ml/min) (mm Hg) (beats/rain) 
G+A (20 mmol/L) 45 _+ 7 71 _+ 8 53 _+ 7 80 _+ 7 90 +_ 5 
K-H 70 _+ 9 90 _+ 9 76 _+ 8 87 +_ 4 98 +_ 5 
p Value 0.04 0.17 0.045 0.34 0.42 
on the aortic cannula of a water-jacketed Langendorff 
perfusion apparatus. All animals received humane care in 
compliance with the guidelines of the Canadian Council 
on Animal Care. Hearts were then perfused at a hydro- 
static pressure of 55 cm H20 with Krebs-Henseleit solu- 
tion maintained at 39 ° _+ 1 ° C. Solution composition (in 
millimoles per liter) was as follows: NaC1 118.0, KC1 4.7, 
NaHCO 3 25.0, MgSO 4 1.2, KI-I2PO 4 1.2, glucose 11.1, and 
CaC12 2.0. The perfusion solution was bubbled with a 
mixture of 95% 02 and 5% CO2 and continuously filtered 
with 5 ~m microfilters (Gelman Sciences Inc., Ann Arbor, 
Mich.). During a 10-minute stabilization period, excess 
mediastinal tissue was removed and the left atrium was 
cannulated with simultaneous ligation of the puhnonary 
veins for conversion to the working mode as described by 
Neely S and modified by Bove and Stammers. 9 In this 
preparation the oxygenated Krebs-Henseleit fluid enters 
the left atrium from a reservoir located 14 cm above the 
heart. The perfusate is ejected into a compliance chamber 
and then against a hydrostatic pressure of 55 cm H20. 
After 15 minutes in the working mode, aortic flow was 
measured with timed collections from the aortic ejection 
line. Coronary flow was measured by timed collections 
underneath t e: heart. Aortic effluent was recirculated and 
filtered continuously, whereas coronary effluent was dis- 
carded. Systolic and diastolic aortic pressures, as well as 
heart rate, were measured continuously with a pressure 
transducer connected to a strip chart recorder. Myocar- 
dial temperature was measured with a needle thermistor 
placed in the right ventricle. Hearts exhibiting coronary- 
to-aortic flow ratios greater than 60% were discarded 
because this ratio level could indicate i schemic  inJury. I° 
The heart was arrested with St. Thomas' Hospital car- 
dioplegic solution containing (in millimoles per liter) 
NaC1 110.0, KCI 16.0, MgCI 2 15.0, CaC12 1.2, and 
NaHCO 3 10.0, pH 7.8, delivered for 3 minutes at a 
temperature of 10 ° C from a height of 55 cm by way of a 
sidearm of the aortic ejection line. To simulate clinical 
conditions, we placed the heart in a cold water bath at 10 ° 
to 15 ° C for i hour and then retrogradely reperfused it for 
10 minutes followed by 30 minutes in the working mode. 
Postischemic aortic and coronary P~ows, as well as systolic 
and diastolic pressures, were measured at 15 and 30 
minutes and were expressed as percentage of control. 
Experimental groups. Hearts were reperfused with 
Krebs-Henseleit solution alone or with the addition of 
L-glutamate and L-aspartate (20 mmol/L; Ajinomoto Co., 
Los Angeles, Calif.)(experiment A) or with Krebs-Hense- 
leit solution alone or with the addition of L-glutamate and 
L-aspartate (20 mmol/L) but with correction of sodium 
content (experiment B). The sodium content of Krebs- 
Henseleit solution was lowered by decreasing the amount 
of sodium chloride used to give a final sodium content hat 
was normal for the solution (144 _+ 0.78 mmol/L). 
Statistical analysis. Data are reported as mean + 
standard error of the mean. Comparison between groups 
was made with the Student's t-test with the level of 
significance at p ~< 0.05. 
Results 
Preischemic ontrol  values are shown for experi- 
ment A in Table I. No significant difference was 
found in hemodynamic  values between the control  
and exper imental  groups. In exper iment A, at the 
end of ischemia, the temperature  of the hearts was 
12.7 ° _+ 0.7 ° C and 11.5 ° _+ 0.7 ° C in group G+A and 
K-H (p = 0.29). Dur ing reperfusion in exper iment 
A, significantly decreased aortic flows and cardiac 
output were seen at 15 minutes; these values were 
independent  of the heart  rate (Table II). Aort ic  
flows were also decreased at 30 minutes of reperfu-  
sion, and, although cardiac output was less, this 
result was not statistically significant (Table II I). 
The sodium content of the L-glutamate and L- 
aspartate (20 mmol/L)  + Krebs-Hensele i t  solution 
without correct ion of sodium was 174 _+ 0.5 mmol/L, 
with osmolar i ty 365 mOsm/kg H20 and pH 7.64 
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Table III. Percent recovery of function at 30 minutes in working mode 
AoF CoF CO SP HR 
Group (rnl/min ) Onl/min ) (ml/min ) (ram Hg) (beats~rain) 
G+A (20 mmoi/L) 28 _+ 7 67 _+ 10 40 _+ 7 71 -+ 8 84 + 11 
K-H 56 ,+ 9 88 + 12 63 ,+ 9 80 ,+ 4 93 _+ 8 
p Value 0.025 0.20 0.06 0.30 0.52 
Abbreviations are given in Table I. 
Table IV. Preischernic ontrol values in experiment B 
AoF CoF CO SP HR 
Group n (ml/min) (ml/rnin) (ml/rnin) (rnm Hg) (beats/rnin) 
G+A (20 retool/L)* 9 25.2 _+ 1.8 12.8 + 0.9 38.1 _+ 2.5 99.6 +_ 4.6 330 _+ 9 
K-H 7 25.4 ,+ 2.7 12.3 _+ 1.1 37.8 _+ 3.6 96.7 _+ 5.3 299 .+ 16 
p Value 0.9 0.95 0.73 0.94 0.69 0.1 
Abbreviations are given in Table I, 
*Sodium corrected 
when bubbled with 95% 0 2 + 5% CO 2 at 39 ° C. The 
slightly alkaline pH is probably a reflection of the 
ability of the Krebs-Henseleit perfusate to buffer the 
acidosis produced by the amino acid additives. Ar- 
rhythmias were frequent and were seen in seven of 
eight hearts during reperfusion. 
Preischemic values for experiment B are shown in 
Table IV with no significant differences in hemody- 
namic parameters noted between groups. At the end 
of ischemia the temperature of the hearts was 12.4 °
_+ 0.5 ° C and 12.5 ° _+ 0.4 ° C in group G+A and K-H 
(p = 0.83). In experiment B hearts were reperfused 
with the amino acid-enriched solution as in exper- 
iment A; however, the sodium content was corrected 
to 146 +_ 0.7 mmol/L, the osmolarity was 291 mOsm/kg 
H20, and the pH was 7.45. No difference was found in 
either aortic flow or cardiac output at 15 or 30 minutes 
of reperfusion (Tables V and VI). Coronary flow was 
significantly increased in the control group at 15 
minutes of reperfusion and may have resulted from an 
atrial leak. No arrhythmias were observed on reperfu- 
sion. 
Discussion 
Experimental studies have shown that glutamate- 
and aspartate-enriched perfusate improved func- 
tional and metabolic recovery of adult myocardium 
after hypoxia. 11'12 Hochachka and .others 13'14 
showed that anaerobic glycolysis was the primary 
pathway for energy production in diving vertebrates 
and that the anaerobic catabolism of the amino 
acids glutamate and aspartate yielded succinate, a
component of the Krebs cycle. Julia and associates is 
showed in puppies that more glutamate was used 
and more succinate was produced after normother- 
mic global ischemia than in a control group. They 
suggested that this may be one mechanism that 
improves the tolerance of the immature heart to 
ischemia. Pisarenko and his group ~6 have shown that 
when glutamic acid, 20 retool/L, was added to a cold 
blood cardioplegic solution in patients undergoing 
repair of Tetralogy of Fallot, tissue levels of gluta- 
mate and adenosine triphosphate were significantly 
higher than in a control group of patients undergo- 
ing the same repair; this correlated with a significant 
difference in cardiac index 2 hours after the opera- 
tion. In a similar fashion, aspartate 17' 18 has been 
shown to improve functional recovery of adult rat 
myocardium when added to cardioplegic solutions. 
We postulated that normothermic amino acid- 
enriched reperfusion of postischemic isolated neo- 
natal working hearts would enhance functional re- 
covery on the basis of the previous studies. An 
ischemic period of 1 hour at temperatures between 
10 ° and 15°C was chosen because of its clinical 
relevance to neonatal cardiac surgery. However we 
have shown that the addition of L-glutamate, and 
L-aspartate, 20 mmol/L, to Krebs-Henseleit solution 
during reperfusion of postischemic neonatal rabbit 
hearts is detrimental to functional recovery. Many 
hearts were arrhythmic in contrast o control hearts 
which were in sinus rhythm at reperfusion. This 
result may be explained by the high sodium content 
and osmolarity of the Krebs-Henseleit solution once 
the monosodium salts of the amino acids have been 
added to it. After correction of the sodium content 
and osmolarity, we found no significant difference in 
functional recovery between control and amino 
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Table V. Pendent recovery of function at 15 minutes in working mode 
AoF CoF CO SP HR 
Group (rnl/min ) (ml/min ) (ml/min ) (ram Hg) (beats~rain) 
G+A (20 mmol/L)* 72 +_ 11 87 _+ 8 77 _+ 9 82 + 5 83 _+ 7 
K-H 73 _+ 7 119 _+ 8 86 _+ 6 87 + 4 97 -+ 2 
p Value 0.95 0.02 0.48 0.40 0.13 
*Sodium corrected. 
Table VI. Percent recovery of function at 30 minutes in working mode 
AoF CoF CO SP HR 
Group (ml/rnin ) (ml/min ) (ml/min ) (ram Hg) (beats/rnin ) 
G+A (20 mmol/L)* 58 _+ 10 87 + 10 67 + 9 77 + 4 84 _+ 6 
K-H 47_+11 114_+15 71_+6 79_+4 97+_3 
p Value 0.50 0.12 0.78 0.79 0.15 
Abbreviations are given in Table I. 
*Sodium corrected. 
acid-enriched reperfusion groups. The approximately 
70% recovery of aortic flow and cardiac output during 
reperfusion i the control group may be attributable to
the calcium content of the St. Thomas' Hospital car- 
dioplegic solution used (1.2 mmol/L). 19' 2o 
The disparity of our results with others may have 
several explanations. Previously, < 12 a model of hyp- 
oxia, a metabolically distinct condition from isch- 
emia, was used. Hochachka and Storey 14 have 
shown that porpoises and other divers have elevated 
levels of aspartate and alanine amino transferases to 
aid in the transition from anaerobic to aerobic 
metabolism. In developing sheep and guinea pig 
hearts, however, decreased activities of these amino 
acid transferases have been have shown. 2>23 Gali- 
nanes and associates 24 have shown the mildly im- 
proved postischemic function of perfused adult rat 
hearts arrested with L-aspartate-enriched (20 
mmol/L) cardioplegic solution to be related to the 
sodium content of the cardioplegic solution and not 
necessarily to the amino acid component. They 
concluded that the ionic composition of amino 
acid-enriched cardioplegic solutions requires con- 
sideration before attributing the cardioprotective 
properties to the additives. Although Weldner and 
associates 4 attributed improved functional recovery 
of 3- to 4-week-old rabbit hearts to enrichment of a 
standard blood cardioplegic solution with L-gluta- 
mate, 20 retool/L, they did not compare this with 
another group where the blood cardioplegic solu- 
tion sodium content was increased by 20 mmol/L. 
The decreased function of hearts exposed to 
monosodium glutamate and aspartate immediately 
after ischemia may also be explained by increased 
sodium-hydrogen a d sodium-calcium exchange re- 
sulting in worsening postischemic reperfusion i ju- 
ry. 25 Nakanishi 26 has shown the negative inotropic 
effect of a solution containing Na--, 200 mmol/L, on 
maximal rate of tension rise of neonatal rabbit 
septa. 
Potential weaknesses of this study are that it was 
performed with the use of crystalloid perfusates and 
the absence of biochemical data. Qui and Hearse 27 
have shown that retrograde blood perfused isolated 
rabbit hearts were more stable, had less coronary 
flow, were more responsive to cardioplegic protec- 
tion, and exhibited asignificantly improved recovery 
of left ventricular pressure after ischemia s com- 
pared with crystalloid-perfused preparations. It may 
be postulated that these amino acids will not be 
effective when added to a crystalloid cardioplegic 
solution at temperatures between 10 ° and 15 ° C. 
The results presented in this article cannot be 
generalized to adult hearts. 
Both glutamate and aspartate are excitatory neu- 
rotransmitters and are neurotoxic at sufficiently high 
concentrations. 28 Newborn mice exposed to sys- 
temic glutamate have experienced retinal injury, 
and, on reaching maturity, have been noted to have 
neurodegenerative lesions. 28 These excitatory neu- 
rotransmitters accumulate under conditions of hyp- 
oxia and ischemia, resulting in increased cellular 
permeability o sodium- and calcium-mediated cell 
death. 29 Deep hypothermia nd total circulatory 
arrest are techniques frequently used in neonatal 
cardiac surgery. We postulate that the use of these 
amino acids during repair of neonatal congenital 
heart disease could contribute to a poor neurologic 
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outcome in addition to the potential detrimental 
effect on the heart. 
In summary we have shown lack of a beneficial 
effect on functional recovery of postischemic neona- 
tal rabbit hearts reperfused with Krebs-Henseleit 
solution enriched with L-glutamate and L-aspartate 
with or without c0rrection of Sodium. We advise 
caution in the use Of these amino acids as cardiople- 
gic additives in neonatal cardiac surgery because of 
their potential neurot0xicity, especially in the setting 
of circulatory arrest. 
we thank Dr. G. F. O. Tyers for his assistance with the 
preparation of the manuscript. 
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